Hints and tips:
Related Special Reports
...Under Gorsky’s tenure, J&J underwent massive growth and became a major player in the rare disease space, notably through the $30bn acquisition of Actelion....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...A version of this article was first published by Nikkei Asia on July 27. ©2022 Nikkei Inc. All rights reserved....
...Lee Dong-geon, an analyst at Shinhan Investment expects Celltrion to grab 15 per cent of the US market for Covid-19 antibody treatments and 25 per cent in Europe, as the company will probably sell its treatment...
...US pharmaceutical executives have been put on notice that they could be held criminally liable for fuelling America’s epidemic of opioid addiction, after the founder of the drugmaker Insys was sentenced...
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...Grace Lee, a professor of paediatrics at Stanford University who sits on the committee, said: “The benefit/risk balance to me is unclear without having a risk estimate of this particular potential adverse...
...Amazon ventured into pharmaceuticals in 2018 when it paid about $1bn to buy PillPack, a mail-order pharmacy that packages and delivers tablets by post....
...It is the largest deal struck by J&J since it acquired Actelion, the European biotech group, for about $30bn in 2017....
...Video of the event on Twitter showed Mr Lee, without a mask, hugging people....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Global and US economic data are beating forecasts and there is growing optimism that corporate profits will do likewise, as the second-quarter earnings season plays out in coming weeks....
...Dave Lee...
...As ever, the FT’s technology correspondent Dave Lee had the full lowdown in our hallowed pink pages, so do read that first if you’re interested....
...Lee Jin-man, an analyst at Seoul brokerage SK Securities, says that alongside companies developing electric car battery technology and new pharmaceutical treatments, entertainment groups like Big Hit are...
...A version of this article was first published by Nikkei Asia on October 19, 2020. ©2020 Nikkei Inc. All rights reserved....
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...jonathan.guthrie@ft.com Letters in response to this column: Focus on the haystack — not on the needles / From Brendan P Geary, Washington, DC, US Active v passive: put more faith in market forces / From...
...Take Lee Ainslie’s Maverick Capital....
...And although China’s pharmaceutical industry has matured a great deal in recent years, it is still far better at incremental innovation than breakthroughs....
...Actelion Pharmaceuticals has agreed to pay $360m to settle civil claims it used a charity to pay illegal kickbacks to patients in the US, the Department of Justice announced on Thursday....
...Andrew Lelling, US attorney for Massachusetts, said it was “the first successful prosecution of top pharmaceutical executives for crimes related to the illicit marketing and prescribing of opioids”....
...But Vivian Lee, who recently joined as president of health platforms at Verily, said she looked forward to spending more time with Google Health....
...He held a series of part-time jobs, working in a garment factory and as a delivery man for a pharmaceuticals company: he also wrote press releases for the National Tuberculosis Centre before landing a job...
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
International Edition